Popular Trials
Subcision + Suction for Acne Scars
Recruiting1 award
Chicago, Illinois
This trial is testing whether using a suction device along with regular acne scar treatments helps improve the scars more than using the regular treatment alone. It targets people with acne scars and aims to see if suction can make the treatment work better by enhancing healing and cleaning.
Alkylating agents
Combo Chemotherapy for Prostate Cancer
Recruiting1 awardPhase 2
Phoenix, Arizona
This trial will test how well a combination of two drugs, carboplatin and cabazitaxel, work in treating patients with metastatic castration sensitive prostate cancer that has progressed after treatment with ADT.
Procedure
Electrophysiological Imaging for Ventricular Tachycardia
Recruiting1 award5 criteria
Halifax, Nova Scotia
This trial is testing a new way to map and treat ventricular tachycardia, which contributes to over 350,000 sudden deaths each year in the US. The new method uses catheter ablation to "block" the channel that forms the circuit, with guidance from 3D images. The hope is that this will improve ablation efficacy and help clinicians identify ablation targets and assess ablation outcome.
Lumason for Vesicoureteral Reflux
Recruiting2 awardsPhase 1
Boston, Massachusetts
This trial is testing a new, safer ultrasound technique that uses a special dye called Lumason to get clearer images of the kidneys. It aims to help diagnose kidney scarring without the need for more expensive and risky tests that involve radiation. The dye helps highlight kidney structures, making it easier for doctors to see any damage.
Popular Filters
Trials for Scarring Patients
Paraffin Wax + Exercise for Scarring
Recruiting1 award2 criteria
Washington, District of Columbia
This trial is testing if paraffin wax can improve the movement and function of scars near joints when used with scar rehabilitation therapy. Participants will use paraffin wax along with their exercise therapy. The
Behavioural Intervention
Scar Treatments for Post-Cesarean Section Pain
Recruiting1 award4 criteria
Scott Air Force Base, Illinois
This trial is comparing two methods to reduce post-surgical pain related to a Cesarean section. One method is scar infiltration with Lidocaine and the other is scar deactivation with acupuncture.
Neurotoxin
Botulinum Toxin for Scarring
Recruiting0 awardsPhase 2 & 3
Detroit, Michigan
This trial will test whether botulinum toxin type A can reduce the appearance of scars when injected into the wound at the time of surgery. The mechanism of action will be investigated by measuring micro RNA profiles at two different points in the healing process.
PDL + Fractional Photothermolysis for Scarring
Recruiting1 award
Chicago, Illinois
This trial tests two types of lasers to improve the look of scars after surgery. It targets patients with post-surgical scars to see if these lasers can make their scars less noticeable. One laser reduces redness, while the other helps smooth out the skin.
Trials for Burn Scars Patients
Laser Therapy
Laser Therapy for Burn Scars
Recruiting1 award
Winnipeg, Manitoba
This trial is testing whether or not laser therapy can help improve the appearance of burn scars. So far, there is evidence that it might be helpful, but more research is needed to know for sure. The laser therapy is expensive, so the researchers want to know if it's worth it before recommending it to patients.
Phase 3 Trials
Neurotoxin
Botulinum Toxin for Scarring
Recruiting0 awardsPhase 2 & 3
Detroit, Michigan
This trial will test whether botulinum toxin type A can reduce the appearance of scars when injected into the wound at the time of surgery. The mechanism of action will be investigated by measuring micro RNA profiles at two different points in the healing process.
Gene Therapy
Gene Therapy for Ornithine Transcarbamylase Deficiency
Recruiting1 awardPhase 3
Aurora, Colorado
This trial is testing DTX301, a treatment designed to help people with late-onset OTC deficiency, a condition that makes it hard for their bodies to process certain proteins. The treatment aims to improve the function of an enzyme that helps manage ammonia levels in the blood. Participants will be monitored for several years, with some continuing in a follow-up program for additional time.
siRNA
Fazirsiran for Alpha-1 Antitrypsin Deficiency
Recruiting1 awardPhase 3
San Antonio, Texas
This trial is testing fazirsiran, a drug that may reduce liver scarring and improve liver health, in patients with liver fibrosis. The drug works by decreasing harmful proteins and reducing inflammation in the liver.
Neurotoxin
Botulinum Toxin for Scarring
Recruiting0 awardsPhase 2 & 3
Detroit, Michigan
This trial will test whether a new medication can reduce scarring compared to using no medication. The study will use two biopsy sites on each person, so that each person serves as their own control. The study hypothesis is that the new medication will lead to less scarring.
Injectable Gel
Injectable Gel for Acne Scars
Recruiting2 awardsPhase 3
Vancouver, British Columbia
This trial is testing a new gel called ELAPR002f to help fill in and smooth out indented acne scars on the face. It targets adults with noticeable acne scars who haven't had success with other treatments. The gel works by filling in the scarred areas to make the skin look smoother. Participants will receive multiple treatments and be monitored for an extended period.
Trials With No Placebo
Paraffin Wax + Exercise for Scarring
Recruiting1 award2 criteria
Washington, District of Columbia
This trial is testing if paraffin wax can improve the movement and function of scars near joints when used with scar rehabilitation therapy. Participants will use paraffin wax along with their exercise therapy. The
Neodyne Device for Scar Improvement in Breast Reconstruction
Recruiting1 award
Stanford, California
This trial is testing a special device called the Neodyne embrace to see if it can make scars look better after breast reconstruction surgery. It focuses on women who have had this surgery using tissue from their abdomen. The device works by reducing skin tension around the scar, which helps it heal more nicely.
Monoclonal Antibodies
Dupilumab for Keloids
Recruiting2 awardsPhase 2
Boston, Massachusetts
This trial investigates whether dupilumab, an anti-inflammatory medication, can help patients with keloids. Keloids are excessive scar tissue growths that current treatments often fail to address effectively. By blocking proteins that cause inflammation, dupilumab may reduce keloid size and improve symptoms.
Behavioural Intervention
Scar Treatments for Post-Cesarean Section Pain
Recruiting1 award4 criteria
Scott Air Force Base, Illinois
This trial is comparing two methods to reduce post-surgical pain related to a Cesarean section. One method is scar infiltration with Lidocaine and the other is scar deactivation with acupuncture.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.